Sulforaphane-decorated gold nanoparticle for anti-cancer activity: in vitro and in vivo studies

References

• Abdull Razis AF, Noor NM. 2013. Sulforaphane is superior to glucoraphanin in modulating carcinogen-metabolising enzymes in Hep G2 cells. Asian Pac J Cancer Prev. 14:4235–4238.
   PubMedGoogle Scholar
• Ahmad MZ, Akhter S, Jain GK, Rahman M, Pathan SA, Ahmad FJ, Khar RK. 2010. Metallic nanoparticles: technology overview and drug delivery applications in oncology. Expert Opin Drug Deliv. 7:927–942.
   PubMed Web of Science ®Google Scholar
• Akhter S, Ahmad I, Ahmad MZ, Ramazani F, Singh A, Rahman Z, Ahmad FJ, Storm G, Kok RJ. 2013. Nanomedicines as cancer therapeutics: current status. Curr Cancer Drug Targets. 13:362–378.
   PubMed Web of Science ®Google Scholar
• Akhter S, Ahmad MZ, Ahmad FJ, Storm G, Kok RJ. 2012. Gold nanoparticles in theranostic oncology: current state-of-the-art. Expert Opin Drug Deliv. 9:1225–1243.
   PubMed Web of Science ®Google Scholar
• Akhter S, Zaki Ahmad M, Singh A, Ahmad I, Rahman M, Anwar M, Kumar Jain G, Jalees Ahmad F, Krishen Khar R. 2011. Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern. CPD. 17:1834–1850.
   Google Scholar
• Chaudhary H, Kohli K, Amin S, Rathee P, Kumar V. 2011. Optimization and formulation design of gels of Diclofenac and Curcumin for transdermal drug delivery by Box-Behnken statistical design. J Pharm Sci. 100:580–593.
   PubMed Web of Science ®Google Scholar
• Choi WY, Choi BT, Lee WH, Choi YH. 2008. Sulforaphane generates reactive oxygen species leading to mitochondrial perturbation for apoptosis in human leukemia U937 cells. Biomed Pharmacother. 62:637–644.
   PubMed Web of Science ®Google Scholar
• Clarke JD, Dashwood RH, Ho E. 2008. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 269:291–304.
   PubMed Web of Science ®Google Scholar
• Danafar H, Sharafi A, Kheiri Manjili H, Andalib S. 2017. Sulforaphane delivery using mPEG-PCL co-polymer nanoparticles to breast cancer cells. Pharm Dev Technol. 22:642–651.
   PubMed Web of Science ®Google Scholar
• Daniels JL, Crawford TM, Andreev OA, Reshetnyak YK. 2017. Synthesis and characterization of pHLIP® coated gold nanoparticles. Biochem Biophys Rep. 10:62–69.
   PubMedGoogle Scholar
• Ding Y, Zhou Y-Y, Chen H, Geng D-D, Wu D-Y, Hong J, Shen W-B, Hang T-J, Zhang C. 2013. The performance of thiol-terminated PEG-paclitaxel-conjugated gold nanoparticles. Biomaterials. 34:10217–10227.
   PubMed Web of Science ®Google Scholar
• Duncan B, Kim C, Rotello VM. 2010. Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J Control Release. 148:122–127.
   PubMed Web of Science ®Google Scholar
• Duy Vo D, Rouaud I, Le Devehat F, Gautier F, Barillé-Nion S, Juin P, Levoin N, Boustie J, Grée R. 2016. Preliminary studies on the activity of mixed polyphenol-heterocyclic systems against B16-F10 melanoma cancer cells. MC. 12:419–425.
   Google Scholar
• Egner PA, Chen JG, Wang JB, Wu Y, Sun Y, Lu JH, Zhu J, Zhang YH, Chen YS, Friesen MD, et al. 2011. Bioavailability of sulforaphane from two broccoli sprout beverages: results of a short term, cross-over clinical trial in Qidong, China. Cancer Prev Res. 4:384–395.
   PubMed Web of Science ®Google Scholar
• Fernandes RO, Bonetto JHP, Baregzay B, de Castro AL, Puukila S, Forsyth H, Schenkel PC, Llesuy SF, Brum IS, Araujo ASR, et al. 2015. Modulation of apoptosis by sulforaphane is associated with PGC-1α stimulation and decreased oxidative stress in cardiac myoblasts. Mol Cell Biochem. 401:61–70.
   PubMed Web of Science ®Google Scholar
• Fimognari C, Berti F, Cantelli‐Forti G, Hrelia P. 2005. Effect of sulforaphane on micronucleus induction in cultured human lymphocytes by four different mutagens. Environ Mol Mutagen. 46:260–267.
   PubMed Web of Science ®Google Scholar
• Fimognari C, Hrelia P. 2007. Sulforaphane as a promising molecule for fighting cancer. Mutat Res. 635:90–104.
   PubMed Web of Science ®Google Scholar
• Fimognari C, Sangiorgi L, Capponcelli S, Nüsse M, Fontanesi S, Berti F, Soddu S, Cantelli-Forti G, Hrelia P. 2005. A mutated p53 status did not prevent the induction of apoptosis by sulforaphane, a promising anti-cancer drug. Invest New Drugs. 23:195–203.
   PubMed Web of Science ®Google Scholar
• Gingras D, Gendron M, Boivin D, Moghrabi A, Théorêt Y, Béliveau R. 2004. Induction of medulloblastoma cell apoptosis by sulforaphane, a dietary anticarcinogen from Brassica vegetables. Cancer Lett. 203:35–43.
   PubMed Web of Science ®Google Scholar
• Gooch JL, Yee D. 1999. Strain-specific differences in formation of apoptotic DNA ladders in MCF-7 breast cancer cells. Cancer Lett. 144:31–37.
   PubMed Web of Science ®Google Scholar
• Han J, Talorete TPN, Yamada P, Isoda H. 2009. Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells. Cytotechnology. 59:45–53.
   PubMed Web of Science ®Google Scholar
• Heo DN, Yang DH, Moon HJ, Lee JB, Bae MS, Lee SC, Lee WJ, Sun IC, Kwon IK. 2012. Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials. 33:856–866.
   PubMed Web of Science ®Google Scholar
• Ho E, Clarke JD, Dashwood RH. 2009. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J Nutr. 139:2393–2396.
   PubMed Web of Science ®Google Scholar
• Houghton CA, Fassett RG, Coombes JS. 2013. Sulforaphane: translational research from laboratory bench to clinic. Nutr Rev. 71:709–726.
   PubMed Web of Science ®Google Scholar
• ICH Q2(R1) Guideline. 2005. Validation of analytical procedures: text and methodology. International Conference on Harmonization, Geneva, Switzerland.
   Google Scholar
• Juge N, Mithen RF, Traka M. 2007. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci. 64:1105–1127.
   PubMed Web of Science ®Google Scholar
• Kim M-R, Zhou L, Park B-H, Kim JR. 2011. Induction of G2/M arrest and apoptosis by sulforaphane in human osteosarcoma U2-OS cells. Mol Med Rep. 4:929–934.
   PubMed Web of Science ®Google Scholar
• Kumar A, Shah BA, Singh S, Hamid A, Singh SK, Sethi VK, Saxena AK, Singh J, Taneja SC. 2012. Acyl derivatives of boswellic acids as inhibitors of NF-κB and STATs. Bioorg Med Chem Lett. 22:431–435.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang T, Korkaya H, Liu S, Lee H-F, Newman B, Yu Y, Clouthier SG, Schwartz SJ, Wicha MS, et al. 2010. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res. 16:2580–2590.
   PubMed Web of Science ®Google Scholar
• Myzak MC, Karplus PA, Chung FL, Dashwood RH. 2004. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res. 64:5767–5774.
   PubMed Web of Science ®Google Scholar
• Ong C, Elbarbry F. 2016. A new validated HPLC method for the determination of sulforaphane: application to study pharmacokinetics of sulforaphane in rats. Biomed Chromatogr. 30:1016–1021.
   PubMed Web of Science ®Google Scholar
• Patra CR, Bhattacharya R, Mukherjee P. 2010. Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer. J Mater Chem. 20:547–554.
   PubMed Web of Science ®Google Scholar
• Petri N, Tannergren C, Holst B, Mellon FA, Bao Y, Plumb GW, Bacon J, O’Leary KA, Kroon PA, Knutson L, et al. 2003. Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. Drug Metab Dispos. 31:805–813.
   PubMed Web of Science ®Google Scholar
• Ruan LP, Chen S, Yu BY, Zhu DN, Cordell GA, Qiu SX. 2006. Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model. Eur J Med Chem. 41:605–610.
   PubMed Web of Science ®Google Scholar
• Singh AV, Xiao D, Lew KL, Dhir R, Singh SV. 2004. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis. 25:83–90.
   PubMed Web of Science ®Google Scholar
• Sonavane G, Tomoda K, Sano A, Ohshima H, Terada H, Makino K. 2008. In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloids Surf B Biointerfaces. 65:1–10.
   PubMed Web of Science ®Google Scholar
• Zrieki A, Farinotti R, Buyse M. 2008. Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line. Pharm Res. 25:1991–2001.
   PubMed Web of Science ®Google Scholar